Yes, Repeat Testing is Appropriate and Strongly Recommended
This 20-year-old female should absolutely be retested approximately 3 months after completing treatment for chlamydia, as women in this age group have high rates of reinfection (15-24%) that significantly increase their risk for pelvic inflammatory disease and other serious complications. 1, 2
Why Retesting is Critical (Not Test-of-Cure)
It's essential to understand that this is not a test-of-cure. The guidelines explicitly state that test-of-cure (testing 3-4 weeks post-treatment) is not recommended for non-pregnant women treated with standard regimens unless compliance is questionable, symptoms persist, or reinfection is suspected 1. Testing earlier than 3 weeks can yield false-positive results from residual dead organisms 1.
Instead, this is rescreening for reinfection, which addresses a different clinical problem:
- High reinfection rates: Women previously infected with chlamydia show infection prevalence of 15-24% when retested within several months 1, 3, 4, 5
- Elevated complication risk: Repeat infections confer higher risk for PID compared to initial infection 1
- Common mechanism: Most post-treatment infections result from reinfection because partners weren't treated or the patient resumed sex with a new infected partner 1
Optimal Timing and Approach
Retest at approximately 3 months after treatment completion 1, 2. The guidelines also encourage retesting whenever she next seeks medical care within 3-12 months, regardless of whether she believes her partners were treated 1.
Mathematical modeling supports this 3-month interval, showing peak repeated infections occur between 2-5 months after treatment 3.
Age-Specific Considerations
At 20 years old, this patient falls into the highest-risk category:
- Women aged 15-25 have chlamydia incidence rates of approximately 20 per 100 person-years 5
- Young age (≤25 years) is consistently associated with both new infections and reinfections 5
- CDC specifically prioritizes "recently infected women" as a major priority for repeat testing 1
- Universal screening recommendations exist for sexually active women ≤25 years 2, 6
Common Pitfalls to Avoid
- Don't test too early: Avoid testing before 3 weeks post-treatment to prevent false-positives from dead organisms 1
- Don't assume partner treatment: Retest even if she reports partners were treated, as this is often unreliable 1
- Don't confuse with test-of-cure: This is rescreening for reinfection, not verification of treatment success 1
- Don't skip counseling: Reinforce that she should abstain from sex for 7 days after single-dose therapy or until completing a 7-day regimen, and until all partners are treated 1
Partner Management Context
The high reinfection rates underscore why partner management is critical. Sex partners from the 60 days preceding her diagnosis should be evaluated, tested, and treated 1. If partner treatment is uncertain, expedited partner therapy may be considered 1.